July 28, 2025 — A wave of legal uncertainty has once again cast a shadow over Centene Corporation (NYSE:CNC), as shareholders grapple with the implications of a new class action lawsuit that alleges securities fraud and corporate misrepresentation. The development has sent ripples across the healthcare investment sector and raised
Centene Corporation (NYSE:CNC), a leading healthcare enterprise specializing in managed care services for government-sponsored health programs, has transformed itself over the past four decades from a small regional player into a national powerhouse. Headquartered in St. Louis, Missouri, Centene's rise has been defined by an aggressive acquisition strategy, targeted
Centene Corporation (NYSE:CNC), one of the largest managed healthcare providers in the United States, faced a severe market backlash this week as news of a federal securities fraud investigation rocked the company and its investors. Shares of Centene plunged sharply amid growing concerns over the scope and implications of
Shares of health coverage company Centene (NYSE:CNC)
fell 3% in the morning session after the company was downgraded by Cantor Fitzgerald, which also lowered its price target on the stock. The downgrade from Cantor Fitzgerald analyst Sarah James added to a period of negative sentiment surrounding the health insurer. The negative outlook stemmed from Centene's recent withdrawal of its 2025 financial guidance. The company pulled its forecast after an independent report revealed that its Affordable Care Act (ACA) marketplace plans had slower-than-expected membership growth and higher-than-anticipated morbidity, which is the rate of disease or illness. This resulted in a significant $1.8 billion downward revision in expected revenue.
Shares of health coverage company Centene (NYSE:CNC)
jumped 5.9% in the afternoon session after the company reported second-quarter results that missed earnings estimates, but the stock rallied as investors looked past the disappointment as sales came in ahead of expectations.
Let's delve into the developments on the US markets one hour before the close of the markets on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Explore the S&P500 index on Friday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest and driving market movements.
Wall Street looked set to close the week on a high note, with large-cap benchmarks pushing higher in Friday's midday trading as optimism over corporate earnings and progress on global trade talks provided support for risk assets.
Let's delve into the developments on the US markets in the middle of the day on Friday. Below, you'll find the top gainers and losers within the S&P500 index during today's session.
Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top S&P500 gainers and losers in today's pre-market session.
Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.
Centene Corp's Q2 2025 earnings missed estimates with a loss per share, causing a 10% premarket drop despite revenue beating forecasts. Investors worry over profitability amid withdrawn guidance.
Health coverage company Centene (NYSE:CNC) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 22.4% year on year to $48.74 billion. Its non-GAAP loss of $0.16 per share was significantly below analysts’ consensus estimates.
A Republican lawmaker is facing scrutiny after selling shares in Medicaid provider Centene Corp. (NYSE: CNC) just days before voting to advance legislation that included significant cuts to Medicaid.
